Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Operating Expenses | 82,389 | 39,889 |
| Operating Income | -82,389 | -39,889 |
| Other Income | 14,581 | -12,091 |
| Pre-tax Income | -67,808 | -51,980 |
| Income Tax | 187 | 5 |
| Net Income Continuous | -67,995 | -51,985 |
| Net Income | $-67,995 | $-51,985 |
| EPS Basic Total Ops | -4.05 | -89.61 |
| EPS Basic Continuous Ops | -4.05 | -89.61 |
| EPS Diluted Total Ops | -4.05 | -89.61 |
| EPS Diluted Continuous Ops | -4.05 | -89.61 |
| EPS Diluted Before Non-Recurring Items | -4.05 | N/A |
| EBITDA(a) | $-82,333 | $-39,870 |